AL, B., DA, S., S, B., DR, T., AM, S., & RI, W. (2026). The case for evaluation of double mutant heat-labile toxin as an adjuvant to improve oral cholera vaccine immunogenicity. Frontiers in immunology, 17, 1805998. https://doi.org/10.3389/fimmu.2026.1805998
Chicago Style (17th ed.) CitationAL, Bourgeois, Scott DA, Baqar S, Tribble DR, Svennerholm AM, and Walker RI. "The Case for Evaluation of Double Mutant Heat-labile Toxin as an Adjuvant to Improve Oral Cholera Vaccine Immunogenicity." Frontiers in Immunology 17 (2026): 1805998. https://doi.org/10.3389/fimmu.2026.1805998.
MLA (9th ed.) CitationAL, Bourgeois, et al. "The Case for Evaluation of Double Mutant Heat-labile Toxin as an Adjuvant to Improve Oral Cholera Vaccine Immunogenicity." Frontiers in Immunology, vol. 17, 2026, p. 1805998, https://doi.org/10.3389/fimmu.2026.1805998.